XiMed
Home
Clinical Use
Phase Contrast Imaging
Products in Development
TEAM/Board
XiMed
Home
Clinical Use
Phase Contrast Imaging
Products in Development
TEAM/Board
Early Diagnosis of Breast Cancer
Challenged by a
large uncertainty on Positive Predictive Value
in ACR 4 category (2% - 95%)
Leads to
overconsumption
of Macrobiopsies which are :
Deleterious
for the patient
Time-consuming
for the doctor
Costly
for the Health System
contact@xi-med.com